Skip to main navigation Skip to search Skip to main content

A Randomized Double-Blind, Placebo Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Atorvastatin in Patients with Clinically Isolated Syndrome and High Risk of Conversion to Multiple Sclerosis

Project: Research

Project Details

StatusFinished
Effective start/end date01/1/06 → 02/28/09

Funding

  • National Institute of Allergy & Infectious Disease: $20,272.69